Document ID: chunk:federal_register_of_legislation:F2025L00142:front:0:p2
Version: federal_register_of_legislation:F2025L00142
Segment Type: other
Provision Reference: 
Character Range: 3243–6229

of the urethra attracts ICD‑10‑AM code C68.0 and C68.1, in applying this Statement of Principles the meaning of malignant neoplasm of the urethra is that given in subsection (2).
 3.           For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from malignant neoplasm of the urethra
 1.           For the purposes of this Statement of Principles, malignant neoplasm of the urethra, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's malignant neoplasm of the urethra.
Note: terminal event is defined in the Schedule 1 – Dictionary.
 1.                Basis for determining the factors
On the sound medical‑scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that malignant neoplasm of the urethra and death from malignant neoplasm of the urethra can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.
Note: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.
 1.                Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, malignant neoplasm of the urethra or death from malignant neoplasm of the urethra is connected with the circumstances of a person's relevant service:
 1.           for squamous cell or mixed squamous and urothelial cell carcinomas only, having infection of the urethra with human papilloma virus (HPV) types 16 or 18 before clinical onset;
 2.           having received a cumulative equivalent dose of at least 0.5 sieverts of ionising radiation to the affected site at least 10 years before clinical onset;
Note: cumulative equivalent dose is defined in the Schedule 1 – Dictionary.
 1.           having a urethral diverticulum at the time of clinical onset;
Note: Urethral diverticulum can be acquired and has been associated with infection of the periurethral glands, urethral trauma (e.g. during vaginal delivery), urethral dilatation or catheterisation, and a history of vaginal or urethral surgery (often for stress incontinence).
 1.           inability to obtain appropriate clinical management for malignant neoplasm of the urethra before clinical worsening.
 1.            Relationship to service
        1.           The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
        2.           The factor set out in subsection 9(4) applies only to material contribution to, or aggravation of, malignant neoplasm of